A hepatitis B vaccination programme for inner metropolitan Sydney neonates

R B Reznik1

  • 1Department of Community Medicine, Royal Prince Alfred Hospital, Queen Elizabeth II Rehabilitation Centre, Camperdown, NSW.

Insights

A hepatitis B vaccination program achieved high compliance in a mobile urban population, with an estimated 92% of infants fully protected. This demonstrates successful vaccine delivery in a challenging demographic, crucial for public health.

Area of Science:

  • Public Health
  • Immunology
  • Epidemiology

Background:

  • Hepatitis B poses a significant public health challenge, particularly in diverse urban populations.
  • Previous concerns existed regarding vaccination efficacy in mobile urban communities with high foreign-born populations.

Purpose of the Study:

  • To assess the effectiveness of a hepatitis B vaccination program for high-risk infants in an urban setting.
  • To evaluate vaccination compliance rates in a population with potential barriers to healthcare access.

Main Methods:

  • A follow-up study of 1429 infants enrolled between September 1987 and December 1988.
  • Vaccinations were administered by early childhood center nurses, with adjustments for parental reports.
  • High-risk infants included neonates born to surface antigen-positive mothers, those from high-prevalence countries, Aboriginal infants, and infants of intravenous drug users.

Main Results:

  • 87% of infants received two doses, and 73% received three doses of the hepatitis B vaccine.
  • An estimated 92% of infants achieved full protection when including vaccinations reported by parents.
  • The program demonstrated high compliance rates in a population previously considered difficult for vaccine delivery.

Conclusions:

  • The hepatitis B vaccination program was effective in achieving high compliance among high-risk infants in a mobile urban population.
  • Current state policies for hepatitis B vaccination may not be optimal for reducing surface antigen carriers in the community.
  • Successful implementation highlights the potential for targeted vaccination strategies in diverse urban settings.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...